XORTX Therapeutics Inc. Common Stock (XRTX) is a publicly traded Healthcare sector company. As of August 1, 2026, XRTX trades at $2.09 with a market cap of $3.50M and a P/E ratio of 0.00. XRTX moved +3.22% today. Year to date, XRTX is -25.61%; over the trailing twelve months it is -41.32%. Its 52-week range spans $1.73 to $8.95. Rallies surfaces XRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks XRTX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.09 |
| Market Cap | $3.50M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.95 |
| 52-Week Low | $1.73 |
| Volume | 7.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
XRTX analyst coverage data. Average price target: $0.00.